Sen. Murphy: For-profit hospitals drive up healthcare costs

A report issued Friday by the office of Senator Chris Murphy (D-Conn.) finds that states where for-profit hospitals dominate spend around 3 percent more per Medicare beneficiary than states where not-for-profit hospitals dominate.

The report also notes that hospitals owned by investors tend to be more likely to offer services with high reimbursement, such as open-heart surgery, and less likely to offer unprofitable services such as emergency psychiatric care.

Because the number of hospitals operated by for-profit companies has grown from around 14 percent to around 20 percent in the past 10 years, the possible link between for-profits and higher healthcare spending needs to be monitored, Sen. Murphy said.

“It’s important for consumers and health officials to understand the impact for-profit hospitals have on federal Medicare spending,” Murphy stated in a press release accompanying the report. “As this report shows, at times for-profit hospitals are likely to prioritize their bottom line, and their mere presence in the market can pressure non-profits to prioritize revenue-generating services.”

In Connecticut, the percentage of for-profit hospitals is low. However, late last month, state regulatory filing revealed that for-profit hospital operator Tenet Healthcare Corp., based in Dallas, Texas, is prepared to spend $535 million to acquire and improve four Connecticut hospitals and related subsidiaries. According to the Hartford Business Journal’s analysis of the state filings, Tenet would spend $45 million to buy Waterbury Hospital, with an additional $55 million spent on improvements. In addition, it would pay $150 million plus an additional $85 million for capital and service improvements for Saint Mary’s Hospital. A total of $105 million would be spent on Eastern Connecticut Health Network, which includes Rockville General and Manchester Memorial hospitals. Finally, Bristol Hospital would be acquired for $50 million, plus an additional $45 million in capital improvements.

According to Sen. Murphy’s report, if per-beneficiary spending in Connecticut had been the same as that for states where for-profit hospital operators dominate, Medicare would have spend $173 million more in 2009 for Connecticut beneficiaries than it did.

The full report can be accessed here.

Lena Kauffman,

Contributor

Lena Kauffman is a contributing writer based in Ann Arbor, Michigan.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.